KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest Expenses: 2012-2024

Historic Interest Expenses for Emergent BioSolutions (EBS) over the last 12 years, with Dec 2024 value amounting to $71.0 million.

  • Emergent BioSolutions' Interest Expenses rose 83.13% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year decrease of 23.75%. This contributed to the annual value of $71.0 million for FY2024, which is 19.23% down from last year.
  • As of FY2024, Emergent BioSolutions' Interest Expenses stood at $71.0 million, which was down 19.23% from $87.9 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Interest Expenses ranged from a high of $87.9 million in FY2023 and a low of $31.3 million during FY2020.
  • In the last 3 years, Emergent BioSolutions' Interest Expenses had a median value of $71.0 million in 2024 and averaged $65.4 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first soared by 135.66% in 2023, then decreased by 19.23% in 2024.
  • Emergent BioSolutions' Interest Expenses (Yearly) stood at $31.3 million in 2020, then rose by 10.22% to $34.5 million in 2021, then rose by 8.12% to $37.3 million in 2022, then soared by 135.66% to $87.9 million in 2023, then dropped by 19.23% to $71.0 million in 2024.